Indeed, findings from heterozygous HIF-prolyl hydroxylase-2 +/− (PHD2/EGLN1+/−) mice support this by showing an improved vessel architecture within the tumor but reduced metastasis upon transplantation of PHD2/EGLN1+/+ tumor cells compared to wild-type mice [185]. The gene discussed is EGLN1; the disease is neoplasm.